FDA would limit input of doctors paid by drug firms
Boston Globe - Boston,MA,USA
For instance, in 2006, a FDA panel unanimously agreed to
allow renewed sales of Tysabri, a multiple sclerosis treatment
comarketed by Biogen Idec Inc. of ...
See all stories on this topic

TYSABRI, 1st New Therapy for MS in More Than 10 Years
CCNMatthews (press release) - Toronto,ON,Canada
Chantal Leslie receives an infusion of TYSABRI at a Burlington, ON,
clinic recently. Chantal, aged 30, of Scarborough, Ontario, was \
among the first ...
See all stories on this topic

---

Smart Living
Joliet Herald News - Joliet,IL,USA
South Suburban Neurology of Flossmoor is screening patients
for enrollment in a new study to evaluate the efficacy and safety
of FTY720, a new oral ...
See all stories on this topic

---

'Give chronically sick free prescriptions' The Scotsman Tue, 20 Mar 2007 5:15 PM PDT PRESCRIPTION charges should be scrapped for sufferers of chronic illness, according to a survey commissioned by the Scottish Executive.

Wheelchair gives dog new lease on life
San Antonio Express-News Tue, 20 Mar 2007 4:03 PM PDT
With the help of a compassionate vet and a caring owner, Bandera,
an 8-year-old German Shepherd, has a new lease on life.

Alternative Medicine: Traditional Chinese medicine for multiple sclerosis
Seattle Post-Intelligencer Wed, 21 Mar 2007 3:43 PM PDT
While there is no cure for multiple sclerosis, acupuncturists can offer
significant help managing symptoms and side effects.

Nutra Pharma Announces Publication of Research on Treatment for Multiple Sclerosis RedNova Thu, 22 Mar 2007 7:01 AM PDT Nutra Pharma Corp. (OTCBB: NPHC), a biotechnolo

Inhibiting blood to save the brain
EurekAlert! Thu, 22 Mar 2007 6:23 AM PDT
A fibrous protein called fibrinogen, found in circulating blood and
important in blood clotting, can promote multiple sclerosis (MS)
when it leaks from the blood into the brain, triggering inflammation
that leads to MS-related nerve damage..